Atara Biotherapeutics Inc
ATRA
$9.17-0.11%
Delayed · as of Oct 19, 2026, 2:00 PM ET
Mkt cap
$87.13M
EV/Sales
0.65
P/E ratio
N/A
FY2025 Revenue
$120.77M
EPS (TTM)
$-1.54
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
27.07%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Latest reported ATRA revenue for 2025-12-31 was $120.8M. Net income was $32.7M. Revenue was down 6.3% from 2024-12-31 to 2025-12-31. ATRA currently screens at market cap $87.1M.
Use this ATRA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ATRA income, balance, and cash tables.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company in the Healthcare sector.
Latest cached Atara Biotherapeutics Inc (ATRA) revenue for Dec 31, 2025 was $120.8M. Net income was $32.7M. Statements: https://lician.com/financials/atra
Atara Biotherapeutics Inc (ATRA) market capitalization is $87.1M on the latest cached snapshot.
Atara Biotherapeutics Inc (ATRA) cached previous close $9.18; day range $9.03 – $9.35; volume 4,399. Session quote: https://lician.com/quote/atra
The latest cached ATRA filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/atra